Product Name: Human CTLA-4 / CD152 Antibody (Nurulimab, Research Use)
Catalog Number: NBR-0623
Target Name: CTLA-4 / CD152
Trade Name: Nurulimab
Antibody Drug Description: Nurulimab (also known as BCD 145) is a monoclonal antibody targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) for the treatment of cancer. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD152
Synonyms: CD152; GSE; CD
Target Description: CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4) is a Protein Coding gene. Diseases associated with CTLA4 include Immune Dysregulation With Autoimmunity, Immunodeficiency, And Lymphoproliferation and Celiac Disease 3. Among its related pathways are Gene expression (Transcription) and CD28 co-stimulation. An important paralog of this gene is CD28.
Ensembl: ENSG00000163599
Uniprot: P16410